11-119107769-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001290474.2(C2CD2L):c.28G>T(p.Val10Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000338 in 1,540,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001290474.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2CD2L | ENST00000648610.2 | c.28G>T | p.Val10Leu | missense_variant | 1/14 | NM_001290474.2 | ENSP00000497391.1 | |||
C2CD2L | ENST00000336702.7 | c.28G>T | p.Val10Leu | missense_variant | 1/14 | 1 | ENSP00000338885.3 | |||
DPAGT1 | ENST00000409993.6 | c.-990C>A | 5_prime_UTR_variant | 1/11 | 2 | ENSP00000386597.2 | ||||
C2CD2L | ENST00000527854.1 | n.*11G>T | downstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 151924Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000666 AC: 11AN: 165044Hom.: 0 AF XY: 0.0000318 AC XY: 3AN XY: 94378
GnomAD4 exome AF: 0.0000151 AC: 21AN: 1388122Hom.: 0 Cov.: 32 AF XY: 0.0000145 AC XY: 10AN XY: 690616
GnomAD4 genome AF: 0.000204 AC: 31AN: 152030Hom.: 0 Cov.: 30 AF XY: 0.000215 AC XY: 16AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2024 | The c.28G>T (p.V10L) alteration is located in exon 1 (coding exon 1) of the C2CD2L gene. This alteration results from a G to T substitution at nucleotide position 28, causing the valine (V) at amino acid position 10 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at